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Coordinated Induction by IL15 of a TCR-Independent
NKG2D Signaling Pathway Converts CTL into
Lymphokine-Activated Killer Cells in Celiac Disease
anisms regulating cytolytic functions in the tissue micro-
environment (Groh et al., 2001, 2003; Jabri et al., 2000,
2002; Roberts et al., 2001; Speiser et al., 1999). By upreg-
ulating the expression of MIC, ULBP, and HLA-E (Bauer
et al., 1999; Braud et al., 1998; Cosman et al., 2001; Lee
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and signaling have been identified: DAP12, DAP10,
CD3, and FcRI. ITAM-bearing DAP12 can induce a
full signaling cascade resulting in cytolysis, cytokineSummary
secretion, and proliferation (reviewed in Lanier, 2001;
Raulet, 2003; Vivier et al., 2002; Yokoyama, 2000), whereasA major function of NKG2D linking innate and adaptive
YXXM-bearing DAP10 seems to exert mainly costimula-immunity is to upregulate antigen-specific CTL-medi-
tory functions (Groh et al., 2001; Wu et al., 1999), al-ated cytotoxicity in tissues expressing stress-induced
though it is capable of directly activating NK cell cyto-NKG2D ligands, such as MIC, by coactivating TCR
lytic function (Billadeau et al., 2003; Zompi et al., 2003).signaling. Here, we show that, under conditions of
Activated mouse NK cells express a splice variant ofdysregulated IL15 expression in vivo in patients with
NKG2D that associates with DAP12 and induces bothceliac disease and in vitro in healthy individuals, multi-
cytolysis and cytokines (Diefenbach et al., 2002; Gilfillan
ple steps of the NKG2D/DAP10 signaling pathway
et al., 2002). However, a splice variant capable of associ-
leading to ERK and JNK activation are coordinately ating with DAP12 appears to be lacking in humans (T.S.,
primed to activate direct cytolytic function indepen- unpublished data).
dent of TCR specificity in effector CD8 T cells. These The emerging diversity and plasticity of the NKG2D
findings may not only explain previous reports of trans- signaling pathways in NK cells suggested, therefore,
formation of CTL into NK-like “lymphokine-activated that, under some conditions, T cells themselves could
killers” (LAK cells) under high doses of IL2 (a substitute be directly activated. Of particular relevance are reports
for IL15) but may also have significant implications for of TCR-independent cytolytic activity of CTL cultured
understanding and treating immunopathological dis- with high doses of IL2 or IL15 (so-called LAK cells) pub-
eases. lished several years ago (Brooks, 1983; Gamero et al.,
1995), as high doses of IL2 can substitute for IL15, a key
Introduction cytokine for NK cell differentiation and effector/memory
T cell survival and activation (Fehniger and Caligiuri,
Recent studies demonstrating a broad expression of NK 2001; Waldmann and Tagaya, 1999). Furthermore, we
lineage receptors of the NKG2 family by CD8 TCR previously reported that, in celiac disease, intraepithelial
effector CTL have revealed the existence of novel mech- intestinal CTL expressed high levels of NK cell-associ-
ated receptors and expanded massively under high ex-
posure to IL15 in the epithelial compartment (Jabri et*Correspondence: bjabri@bsd.uchicago.edu
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Figure 1. Induction of NKG2D Function in
Normal Intestinal CTL by IL15 and High Doses
of IL2
(A) Kinetics of NKG2D upregulation by IL15
in TCRCD8 CTL. Surface levels of
NKG2D in intraepithelial CTL freshly isolated
from normal subjects and incubated with
IL15, IL12, or IL7 as indicated were deter-
mined. Increased mean fluorescence inten-
sity (SEM) of TCRCD8 gated cells is
shown as ratio of cytokine-treated over me-
dium alone. Data are representative of three
independent experiments.
(B) Induction of NKG2D-mediated cytolysis
by IL15 and IL2, measured with 51Cr-labeled
FcR P815 targets in the presence of anti-
NKG2D or anti-CD3 mAb at E/T ratio 33:1.
Data are representative of three independent
experiments. In the right panel, different con-
centrations of anti-NKG2D mAb were used
to elicit cytolytic activity from IEL pretreated
with IL15 or IL2 as indicated.
(C) Left: Cytolysis of C1R/MIC transfectants
and erythroleukemia K562 cell line. Freshly
isolated intraepithelial CTL incubated for 48 hr with cytokines or medium as indicated, intraepithelial CTL lines derived from normal individuals,
or CD8TCR TALL-104 leukemia line expressing high levels of NKG2D were used as effector T cells. Right: Blocking of C1R/MIC lysis by
intraepithelial CTL lines with different concentrations of anti-NKG2D 1D11 mAb or isotype control. Data are representative of two indepen-
dent experiments.
(D) Cytolytic granule release measured by BLT esterase assay. Receptor ligation with monoclonal anti-NKG2D or -CD3 mAb, but not with
isotype control, triggered granule release in intraepithelial CTL lines. The data are representative of three independent experiments.
in HLA-DQ2 and DQ8 individuals and, while the presence CTL, CD3 engagement was effective in inducing lysis
ex vivo (Figure 1B). In addition, NKG2D mediated lysisof gluten-specific DQ2- or DQ8-restricted CD4 T cells
is well established in the lamina propria (Koning, 2003; of C1R/MIC but not control cells in TCRCD8 CTL
lines cultured with 100 U/ml IL2 or 20 ng/ml IL15 andSollid, 2000), a key pathologic event is a massive cell
death in the epithelial compartment infiltrated by IL15- the CD8 leukemia T cell line TALL-104 (Figure 1C, left).
Importantly, intraepithelial CTL preincubated with IL15activated CTL, suggesting the contribution of aberrant
TCR-independent NK-like killing (Green and Jabri, 2003). did not kill K562, a common NK target (Figure 1C, left)
that expressed very low levels of MIC and ULBP pro-Here, we show that IL15 elicits a coordinated series of
biochemical changes in the NKG2D signaling pathway, teins, and C1R/MIC killing was inhibited in the presence
of blocking anti-NKG2D 1D11 mAb (Figure 1C, right).ultimately arming TCR-independent NK-like killing through
NKG2D and effectively converting CTL into LAK cells Finally, ligation of NKG2D receptors with monoclonal
anti-NKG2D mAb triggered granule release by intraepi-both in vitro in culture systems and in vivo in celiac
patients. Because the NKG2D ligand MIC is markedly thelial CTL, as shown by the BLT esterase assay (Figure
1D), ruling out cryptic involvement of other receptor/induced in celiac intestinal epithelial cells, our findings
raise the possibility that IL15-induced LAK cells may ligand pairs for target killing by NKG2D.
significantly contribute to tissue damage in celiac dis-
ease as well as other pathological processes. IL15 Arms NKG2D-Mediated Cytolysis in Effector
but Not in Naive or Resting Memory PBL
The above findings with fresh and cloned intraepithelialResults
CTL contrasted with those reported with PBL-derived
CTL clones where NKG2D engagement alone was insuf-IL15 Arms NKG2D-Mediated Cytolysis in Freshly
Isolated Intraepithelial CTL ficient to induce lysis (Billadeau et al., 2003), suggesting
differential effects of IL15 based on the source or theWe previously showed that NKG2D was expressed at
low levels on all intraepithelial CTL and could be upregu- activation status of the CTL. We therefore examined
naive and resting memory CD8TCR cells obtainedlated by exposure to IL15 (Roberts et al., 2001). Upon
48 hr exposure of fresh intraepithelial CTL to IL15 (but by sorting CD8CD45RO and CD8CD45RO, re-
spectively, from peripheral blood. As shown in Figurenot IL12 or IL7), NKG2D acquired the ability to mediate
cytolysis of both P815 cells (anti-NKG2D redirected ly- 2A, prestimulation with IL15 for up to 3 weeks was not
sufficient to arm NKG2D-mediated lysis. However, shortsis) (Figure 1B) and C1R/MIC transfectants (Figure 1C).
The level of cytolysis paralleled the level of NKG2D in- prestimulation by plate bound anti-CD3 mAb for 24 hr
prior to incubation with IL15 (Figures 2A and 2B, “ef-duction (compare Figures 1A and 1B), reaching up to
40% at an E:T of 33:1. High doses of IL2 (100 U/ml), fector CD8 T-PBL cells”) or with IL2 at high doses (Figure
2B) did arm NKG2D-mediated lysis in both naive andwhich substitute for IL15, but not low doses (30 U/ml),
were also effective in arming NKG2D-mediated killing resting memory cells, suggesting that activation of the
NKG2D pathway of cytolysis by IL15 is restricted to the(Figure 1B, right). In contrast, as expected from effector
LAK Conversion of CTL by IL15 in Celiac Disease
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levels of cytolysis (	10% specific lysis) in 6/7 active
celiac patients, but not in 4/4 celiac patients under GFD
and 12/12 individuals with a normal intestine, either in
redirected cytolysis assay (3/3) or with MIC-transfected
targets (3/4) (Figure 3B, left). CTL cell lines derived from
celiac intraepithelial CTL induced NKG2D-dependent
killing of various intestinal epithelial cell lines (MIC4,
LOVO, INT-407, HCT-116) expressing the NKG2D li-
gands MIC or ULBP, albeit with variable efficiency (see
a representative experiment in Figure 3B, right). Impor-
tantly, intraepithelial celiac CTL did not kill the NK target
K562, which expresses very low levels of MIC and ULBP
ligands, suggesting that these celiac CTL lacked the
activating NK receptors required to kill K562.
Altogether, these results support a scenario whereby,
upon IL15 exposure in vivo, celiac intraepithelial CTLFigure 2. IL15 and High IL2 Can Arm NKG2D in Effector but Not in
Naive or Resting Memory Peripheral Blood CTL have turned on NKG2D-mediated NK-like cytolytic ac-
tivity.(A) Purified CD45RO and RO TCRCD8PBL subsets were cul-
tured with IL15 for 3 weeks with (effector T cells) or without (naive
and resting memory T cells) overnight prestimulation with plate MIC Expression Is Upregulated in Active Celiac IEC
bound anti-CD3 mAb. NKG2D-mediated lysis was measured against MIC is constitutively expressed on the surface of IEC
C1R/MIC transfectants. Specificity controls included C1R/NEO cells
(intestinal epithelial cells) in the colon (Groh et al., 1996;as well as blocking with anti-NKG2D 1D11 mAb (data not shown).
and unpublished data), but it is usually present at very(B) Purified TCRCD8 PBL were prestimulated with plate bound
low levels on normal small bowel IEC. We studied MICanti-CD3 overnight (effector) prior to incubation with IL15 or IL2 at
30 or 300 U/ml for 3 weeks as indicated. Data are representative of expression by flow cytometry (n
 20) and immunohisto-
two independent experiments. chemistry (n 
 18) in control, active celiac patients, and
patients under GFD. As shown in Figure 3C, around 25%
of IEC expressed high levels of MIC on their surface in
effector stage of CTL. We extended these observations 4/5 active celiac patients, but not in normal controls
to cultured CTL lines by showing that IL15 activated (n 
 11) and in patients under GFD (n 
 4). In frozen
the NKG2D cytolytic pathway only if the cells had been sections of the small intestine, as shown in a representa-
recently restimulated (3 weeks) through their antigen tive example in Figure 3D, IEC from normal (n 
 6) and
receptor (data not shown). GFD (n 
 6) individuals expressed little MIC, whereas,
Altogether, these results suggest that CD8 T cells in marked contrast, 5/6 active celiac patients expressed
need to be in an effector stage in order for IL15 to arm very high levels of MIC in surface and crypt IEC. Alto-
NKG2D-mediated lysis. gether, these results show a strong correlation between
MIC induction on small bowel IEC and the ingestion of
gluten by celiac patients. This upregulation of MIC is
Fresh Intraepithelial CTL from Active Celiac Patients particularly significant in the context of the upregulation
Mediate TCR-Independent Lysis through NKG2D of NKG2D-mediated cytolytic properties of intraepithel-
without the Need for IL15 Prestimulation ial CTL.
Because, in celiac disease, expanded intraepithelial CTL
are constitutively exposed to very high amounts of IL15 Human NKG2D Is Selectively Associated
(Jabri et al., 2000; Mention et al., 2003), we tested with DAP10
whether they expressed high levels of NKG2D and could Because DAP12-dependent NKG2D-mediated killing by
mediate direct cytolysis through NKG2D. Intraepithelial NK cells was shown in mice (Diefenbach et al., 2002;
CTL freshly isolated from the biopsies of active celiac Gilfillan et al., 2002), we investigated whether NKG2D
patients (n
 15) consistently expressed NKG2D at 4–20 was associated with DAP12. We found that NKG2D co-
(average 6.5) times higher levels than normal intraepi- precipitated with DAP10 but not with DAP12, even when
thelial CTL (n
 17) (Figure 3A). NKG2D levels decreased DAP12 was expressed (Figure 4A). We also verified that
conspicuously under GFD (gluten-free) diet (n 
 9), NKG2D was not associated with other ITAM-bearing
though they remained slightly elevated even after 1–2 adaptors, such as TCR CD3 and FcRI chains (data
years, in accordance with the finding that IL15 does not not shown). Finally, unlike CD3, NKG2D did not induce
return to complete normalcy under GFD (Mention et ZAP70 phosphorylation, further supporting the notion
al., 2003). Two representative experiments with multiple that NKG2D signaling does not involve an ITAM-bearing
samples examined on the same day are shown in Figure adaptor molecule such as DAP12 (Figure 4B). These
3A along with a summary display of data from all 41 results are in agreement with the findings that NKG2D
samples. It is noteworthy that, in active celiac disease, could not mediate proliferation and cytokine secretion
NKG2D was expressed at levels comparable to those in CTL (Roberts et al., 2001; data not shown).
observed after prestimulation of normal intraepithelial
CTL with IL15 for 48 hr (compare NIL15 with AC in ERK and JNK Activation Are Critical
Experiment 1, Figure 3A). The higher level of NKG2D for NKG2D-Mediated Lysis in CTL
expression in fresh celiac intraepithelial CTL correlated In order to determine the signaling pathways involved
in NKG2D-mediated cytolysis in human CTL, we firstwith the observation that NKG2D mediated significant
Immunity
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Figure 3. Constitutive Activation of NKG2D
in Intraepithelial CTL and Expression of MIC
in IEC from Active Celiac Patients
(A) Surface NKG2D levels on freshly isolated
TCRCD8 intraepithelial CTL from active
celiac patients, celiac patients under GFD,
and healthy individuals. Two representative
experiments are shown. Note that in Experi-
ment 1, normal (N), GFD, and active celiac
patient (AC) were stained the same day with
the same antibody mix. Normal intraepithelial
CTL incubated with IL15 for 48 hr are shown
for comparison. In Experiment 2, GFD and
AC were stained the same day. A dot plot
summarizing all samples investigated is
shown in the right panel. Statistical signifi-
cances of the differences in NKG2D mean
fluorescence intensity (MFI) between the
three groups were calculated by analysis of
variance (ANOVA), followed by Tukey’s ad-
justment for multiple comparisons.
(B) Left: Cytolytic activity of freshly isolated
normal and celiac intraepithelial CTL against
51Cr-labeled FcR P815 targets in the pres-
ence of anti-NKG2D or isotype-matched con-
trol mAbs or against 51Cr-labeled C1R/MIC
versus C1R/Neo targets. Right: Celiac CTL
lines killed 51Cr-labeled intestinal MIC cell
lines (MIC4, LOVO, INT-407) but not MIC/
ULBP-negative/low K562 cells. Killing was
significantly blocked by anti-NKG2D 1D11
mAb or by anti-MIC 6D4 mAb. Data are repre-
sentative of three independent experiments.
(C) Flow cytometry analysis of freshly isolated
IEC (ESA) from active celiac patients shows
surface MIC. The dot plot summarizes the %
of MIC IECs in normal, GFD, and active ce-
liac patients. Statistical significances were
evaluated using a nonparametric, Kruskal-
Wallis test.
(D) Immunohistochemical analysis of MIC ex-
pression in IEC of active celiac patients, ce-
liac patients under GFD, and controls. Upper
panels, intestinal villi; lower panels, intesti-
nal crypts.
studied the effects of a panel of kinase inhibitors on ERK and JNK. As shown in Figure 5B (upper left), ERK
phosphorylation peaked at 5 min after NKG2D stimula-NKG2D- versus TCR-mediated killing in celiac and nor-
mal intraepithelial CTL lines. Redirected cytolytic assays tion and returned to basal level after 30 min. Likewise,
JNK was activated 15 min after NKG2D stimulation usingwere performed using concentrations of anti-CD3 and
anti-NKG2D that elicited comparable levels of cytotoxic- a JNK kinase assay (Figure 5B, upper right) and returned
to basal levels after 30 min. Similar results were ob-ity (Figure 5A). All the results obtained with anti-NKG2D
were confirmed in cytolytic assays using C1R/MIC served with an antibody directed against the phosphory-
lated form of JNK (data not shown). ERK phosphoryla-transfectants (data not shown). Pretreatment of CTL with
the PLC- inhibitor U73122 (but not with the inactive tion was dramatically reduced in cells pretreated with
wortmannin and PD98059, but not with the p38 inhibitoranalog U73343) and the PI3-kinase inhibitors wortman-
nin and Ly294002 suppressed NKG2D and TCR-medi- SB203580 (Figure 5B, lower left). In contrast, wortman-
nin did not block JNK activation, whereas the JNK inhibi-ated lysis. In contrast, the MEK1/2 inhibitor PD98059
and the JNK inhibitor SP600125 inhibited NKG2D but tor SP600125 did (Figure 5B, lower right).
Altogether, these results suggest that NKG2D can me-not CD3-mediated lysis. The p38 inhibitor SB203580
had no effects. The combination of JNK and MEK1/2 diate ERK phosphorylation and JNK activation and that
the catalytic function of PI3-kinase is essential for ERK,inhibitors had additive but not synergistic effect on
NKG2D-mediated lysis (Figure 5A, right), suggesting that but not for JNK activation.
the two pathways were distinct. These results were fur-
ther confirmed in five separate experiments using celiac
CTL lines, normal intraepithelial CTL lines, and the TALL- Coordinated Priming of the NKG2D
Pathway by IL15104 leukemia T cell line (data not shown).
We then investigated whether, as suggested by the Semiquantitative PCR analysis showed 	10-fold in-
crease in both NKG2D and DAP10 transcripts upon IL15pharmacological experiments, NKG2D/DAP10 activated
LAK Conversion of CTL by IL15 in Celiac Disease
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Figure 4. NKG2D Associates with DAP10 and Does Not Mediate
ZAP70 Phosphorylation in CTL
(A) NKG2DCD94/NKG2C cells from a TCR line derived from
active celiac intraepithelial CTL were surface labeled with anti-
CD94, -NKG2D, -MHC class I and -CD3 mAbs prior to immunopre-
cipitation and immunoblotting with antibodies against DAP10 and Figure 5. Role of ERK and JNK in NK62D-Mediated Lysis
DAP12. Note that this CTL line expresses DAP12, which coprecipi- (A) Suppression of NKG2D mediated lysis by ERK and JNK inhibitors.
tates with CD94, but not NKG2D. NKG2Dhigh TCR CTL lines derived from celiac patients were pre-
(B) Ligation of CD3, but not NKG2D, induced ZAP70 phosphoryla- treated for 30 min with various kinase inhibitors prior to a cytolysis
tion. Staining with total anti-ZAP70 mAb demonstrates equal loading. assay against FcR P815 targets in the presence of anti-CD3 mAb
(black) or anti-NKG2D mAb (white). Data represent three indepen-
dent experiments. The percentage of inhibition was calculated by
stimulation of normal fresh intraepithelial CTL (Figure reference to DMSO-treated CTL. Similar results were obtained using
normal subjects’ intraepithelial CTL and TALL-104 (data not shown).6A). This finding was confirmed by real-time PCR show-
Note that MEK1/2 inhibitor and JNK inhibitors block NKG2D but noting 9.5-fold  0.67-fold increase in NKG2D mRNA and
CD3-mediated lysis and have an additive effect on NKG2D-mediated12.3  0.48 increase in DAP10 mRNA over CTL in me-
cytolysis (right).dium alone. We have shown increased surface NKG2D (B) NKG2D signaling activates PI3 kinase, ERK, and JNK. Celiac
in Figure 1A and found here that DAP10 protein was TCR CTL lines were stimulated with anti-NKG2D, isotype-
markedly induced as well, whereas the total amount of matched control Ig, or medium followed by crosslinking with F(ab’)2
goat anti-mouse IgG for the indicated duration before lysis. UpperCD3 remained unchanged (Figure 6B). Because the PI3
panels: Time course of ERK and JNK activation. Phosphorylationkinase→ERK signaling pathway is critical for NKG2D-
of ERK is shown by direct immunoblotting with an anti-phosphomediated cytolysis, we investigated whether IL15 could
ERK mAb. After JNK pull-down by c-Jun-N-GST fusion protein, ac-induce ERK phosphorylation in normal freshly isolated tive JNK was tested in a kinase assay by immunoblotting with anti-
intraepithelial CTL. As shown in Figure 6C, ERK phos- phospho-c-Jun. Equal loading shown by antibody to total ERK and
phorylation occurred within 5 min of stimulation by IL15, c-Jun. Lower panels: Lysates from cells incubated for 30 min with
the indicated kinase inhibitors or DMSO were treated as specifiedbut not IL7. Furthermore, pretreatment of CTL with the
for the upper panels. PI3 kinase inhibitor WM blocked ERK butPI3-kinase inhibitor wortmannin or the MEK1/2 inhibitor
not JNK activation. These experiments are representative of sixPD98059 inhibited ERK phosphorylation, whereas the
independent experiments using different celiac and normal intraepi-p38 inhibitor SB203580 had no effect (Figure 6D). thelial TCR CTL line, and the TALL-104 CTL leukemia cell line.
Altogether the results indicate that IL15 promotes
NKG2D-mediated signaling and cytolysis by coordi-
nately increasing the levels of NKG2D and DAP10 ex- intraepithelial CTL (Figures 7C and 7D). After GFD, the
pattern of phospho-ERK1/2 expression returned to nor-pression and by inducing the phosphorylation of ERK
in a PI3 kinase-dependent manner. mal (Figure 7B). Altogether, these results suggest that
ERK is activated in celiac CTL and that this activation
might be, at least in part, promoted by IL15.Upregulation of Phospho-ERK in Celiac IEC
and Intraepithelial CTL
Because IL15 is highly upregulated in celiac epithelial Discussion
cells (Jabri et al., 2000; Mention et al., 2003) and because
IL15 induces ERK phosphorylation in intraepithelial CTL There have been many reports that CD8TCRT cells
in long-term culture with high concentrations of IL2 or(Figure 6) and in epidermal cell lines (Yano et al., 2003),
we investigated whether phospho-ERK1/2 was upregu- IL15 become so-called lymphokine-activated killers
(LAK cells) with NK-like cytolytic function, i.e., the abilitylated in celiac intraepithelial CTL and IEC. Expression
of phospho-ERK1/2 was studied by immunohistochem- to kill tumor targets seemingly independent of TCR
specificity (Brooks, 1983; Gamero et al., 1995). Theseistry in fixed biopsy samples of three normal, three GFD,
and three active celiac patients using anti-phospho- observations conflicted with the dogma that TCR speci-
ficity is the primary driving force during peripheral acti-ERK1/2 mAb. In normal gut epithelium, some phospho-
ERK1/2 could be detected in a few crypt epithelial cells vation and target killing. Because this conversion into
so-called LAK cells might have resulted from aberrantbut not in the surface epithelium or in intraepithelial CTL
(Figure 7A), whereas active celiac samples exhibited a changes induced in vitro, neither the mechanism(s) nor
the in vivo relevance of this transformation into LAK havedramatic upregulation of phospho-ERK1/2 in all IEC and
Immunity
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Figure 6. Coordinated Induction by IL15 of
NKG2D and DAP10 Expression and ERK
Phosphorylation in Normal Freshly Isolated
Intraepithelial CTL
(A) Semiquantitative RT-PCR analysis of freshly
isolated cells cultured with medium alone or
with 20 ng/ml IL15 for 48 hr.
(B) DAP10 and CD3 immunoblot on total cell
lysates of fresh normal intraepithelial CTL and
control 293T fibroblast. (A) and (B) are repre-
sentative of two separate experiments.
(C) Total lysates of freshly isolated intraepi-
thelial CTL prestimulated for the indicated du-
ration with IL15 or IL7 were analyzed by im-
munoblotting with anti-phospho-ERK and
reprobed with antibody to ERK to assess
equal loading. One experiment representative of three is shown.
(D) Total lysates from cells incubated with the indicated kinase inhibitors or control DMSO prior to IL15 stimulation were treated as in (C).
been decisively pursued. The present study of normal secretion and proliferation are mediated by ITAM-con-
taining immunoreceptors such as DAP12 or CD3 inintestinal CTL exposed to IL15 in vitro and of celiac CTL
that are naturally exposed to IL15 in vivo provides both lymphocytes (Lanier, 2001; Raulet, 2003; Vivier et al.,
2002; Zompi et al., 2003) and that NKG2D in humana mechanism and a physiopathological correlate for the
LAK cell conversion involving specifically the NKG2D/ CTL exclusively associates with DAP10 but not DAP12
or CD3.MIC receptor/ligand system. It is also possible, but re-
mains to be directly tested, that additional activating The main signaling pathways controlling NK lysis have
been proposed to include a PI3 kinase→Rac I→MEK1/NK receptor/ligand systems (Lanier, 2001) might be in-
volved in other cases, allowing LAK cells to kill NKG2D 2→ERK pathway that effects tumor lysis (Jiang et al.,
2000) and a Syk-independent pathway involving PI3 ki-ligand-negative target cells as well.
While both human and mouse NK cells were pre- nase, PLC-2, Vav1, and Rho family GTPases that con-
trols NKG2D-mediated lysis (Billadeau et al., 2003).viously found to induce cytolysis upon NKG2D engage-
ment (Billadeau et al., 2003; Zompi et al., 2003), the While there is no evidence for Vav upstream of PI3 ki-
nase, NKG2D stimulation can directly recruit PI3 kinasesame effect could not be documented in human TCR
CTL, which nonetheless constitutively express NKG2D by DAP10 via its PI3 kinase binding-motif YNIM (Wu
et al., 1999). Our studies have not only extended the(Bauer et al., 1999; Billadeau et al., 2003). In contrast,
studies looking at effector T cells (Roberts et al., 2001) importance of these signaling pathways in TCR CTL,
but importantly also brought ERK and JNK activationor tumoral leukemia TCR CTL (Verneris et al., 2003)
suggested that IL15 or high concentrations of IL2 could into the general picture. The results obtained with the
pharmacological inhibitors of kinases further suggestedarm NKG2D-mediated lysis in TCR CTL. Our study
provides potential explanations for these seemingly that ERK was downstream of PI3 kinase while JNK acti-
vation was independent of PI3 kinase. The involvementcontradictory findings. First, the history of exposure to
IL15 in vivo or to high doses of IL2 as a substitute in vitro, of two signaling pathways, one leading to Vav and JNK
activation and the other to PI3 kinase and ERK phos-may be a determining factor that is likely to differ widely
with the source of T cells and the protocols of cell culture phorylation, is further supported by the fact that JNK
activation is independent from ERK phosphorylation andand cloning. Second, we have shown that the activation
status of the CD8 T cells, e.g., naive versus memory that ERK and JNK seem to act in an additive rather than
synergistic manner to mediate NKG2D lysis. However,versus effector, is a critical factor as well, since only
effector CTL (as defined by the ability to induce target because cytolysis is a complex effector function, it is
possible that additional signaling pathways may be nec-cytolysis immediately upon TCR engagement), whether
directly isolated from human tissues or generated in vitro essary.
A key factor in arming the NKG2D-mediated cytolysisafter TCR-mediated activation of resting CTL, could be
turned into LAK cells. Another particularly relevant ex- pathway of TCR effector CTL appears to be IL15.
This observation is supported by the notion that IL15ample of such differences is illustrated by the report
that IL15 in absence of TCR stimulation could upregulate plays a critical role for the survival of memory/effector
T cells (Fehniger and Caligiuri, 2001; Waldmann andnoninhibitory CD94 receptors in effector CTL but not in
resting memory CD45ROCD8 PBL (Jabri et al., 2000). Tagaya, 1999) or in pathological conditions associated
with high IL15 (Fehniger et al., 2001; Groh et al., 2003;Finally, it is possible that NKG2D-mediated cytolysis
requires the coengagement of other unidentified recep- Jabri et al., 2000; Mention et al., 2003; Roberts et al.,
2001). In our study, the hyperinduction by IL15 of NKG2Dtors by killer cells themselves through homotypic inter-
actions. and DAP10 seemed to be a determining factor in the
ability of NKG2D to mediate cytolysis. This is supportedIt is relevant to note, however, that even though
NKG2D was able to trigger target cytolysis by effector by the finding that there is a threshold in NKG2D engage-
ment that triggers lysis and that a reduction in the levelCTL independently of their TCR specificity, it could not
induce functions with a systemic effect such as cytokine of NKG2D by tumor-derived soluble MIC drastically im-
paired NKG2D-mediated killing (Groh et al., 2002). How-secretion or proliferation (data not shown; Roberts et
al., 2001). This is likely due to the fact that cytokine ever, this is probably not sufficient, and the coordinated
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Figure 7. Phospho-ERK 1/2 Expression in
IEC and Intraepithelial CTL of Active Celiac
Patients
Single staining with anti-Phospho-ERK1/2
mAb shows only scarce expression in crypt
epithelial cells of normal controls (A) and pa-
tients under GFD (B). In contrast, phospho-
ERK is very highly expressed in surface and
crypt IEC and intraepithelial CTL of active ce-
liac patients (C). Double staining with anti-
phospho-ERK1/2 (brown) and anti-CD3 (red)
mAbs shows phospho-ERK1/2 in intraepi-
thelial CTL (D). Isotype IgG2a control staining
is shown in (E). (A), (B), and (C), 20 magnifi-
cation; (D) and (E), 40. One representative
experiment out of three is shown.
activation of PI3 kinase and ERK, and possibly of other TCR activation threshold of CTL have raised the possi-
bility that they might play a role in autoimmunity as wellcomponents of the NKG2D pathway, provide another
level of functional cooperation required to initiate the (Groh et al., 2003; Roberts et al., 2001). The present
study further suggests that NKG2D might promote dele-cytolytic program.
These findings have significant implications for our terious autoimmune responses by mediating direct kill-
ing of stressed tissue cells independently of TCR en-general understanding of how signaling through the
same surface receptor can be modulated in different gagement. However, our findings also indicate that
periodic reactivations of TCR in an IL15-rich environ-cell types or in different activation stages of the same
cell type. Our observations in celiac disease suggest a ment are required to maintain this dangerous property
of NKG2D. One would envision, therefore, that inductionnew physiopathological dimension in vivo to the acquisi-
tion of in vitro LAK activity by these T cells. The pathol- of NKG2D/MIC in chronic disease might reveal latent
(low-affinity) crossreactivity to self-antigens and initiateogy of celiac disease is the consequence of a massive
epithelial cell death leading to widespread villous atro- an aberrant positive feedback loop resulting in the am-
plification and propagation of deleterious cytolyticphy. While gluten-specific DQ2- and DQ8-restricted CD4
T cells are restricted to the lamina propria (reviewed in LAK cells.
In normal conditions in the gut, where IEC are exposedKoning, 2003; Sollid, 2000), the epithelium is the site of
a massive TCR CTL expansion, which likely contrib- to pathogens, the crosstalk between IEC and intraepi-
thelial CTL mediated by NKG2D and its ligands mightutes to epithelial damage in an antigen-nonspecific
manner (Green and Jabri, 2003). Our study supports a be critical to maintain a healthy epithelium by helping
to eliminate infected cells. However, in conditions ofmodel in which intraepithelial CTL kill MIC expressing
IEC through NKG2D upon stimulation by IL15 in active uncontrolled IL15 expression by IEC, such as seen in
celiac disease, arming NKG2D-mediated killing inde-celiac disease. NKG2D activation by IL15 requires the
CTL (fresh cell or cultured line) to be in an effector stage pendent of TCR specificity might lead to indiscriminate
epithelial cell destruction and tissue atrophy. These find-when it encounters IL15. These conditions are naturally
achieved in the high antigenic environment of the gut ings may provide the basis for novel therapeutic ap-
proaches in celiac disease aiming at suppressing un-when IEC express inordinately high levels of IL15 on
their cell surface (Jabri et al., 2000; Mention et al., 2003), controlled CTL activation and conversion into LAK by
blocking IL15 or NKG2D. Conversely, given the wide-likely associated with IL15R (Dubois et al., 2002), during
gluten exposure. Intraepithelial TCR CTL of active spread expression of NKG2D ligands by transformed
cells, administration of IL15 might be useful to promoteceliac patients exhibit the hallmarks of IL15 exposure,
e.g., high levels of CD94 (Jabri et al., 2000) and NKG2D, tumor eradication in conditions when antigen-specific
rejection is limiting, as well as prevent NKG2D down-the accumulation of phospho-ERK, and the ability to kill
MIC-expressing targets independently from TCR en- modulation by soluble MIC secreted by tumor cells.
gagement. Closing the loop is the observation that MIC
is induced on intestinal epithelial cells during active ce-
Experimental Procedures
liac disease, providing the target for NKG2D-mediated
killing. Although the early mechanisms causing MIC and Patients and Controls
Sixty adult patients (age: 16–78 years) with active celiac diseaseIL15 overexpression by IEC and their link to CD4 T cell
were investigated. Diagnosis of celiac disease was based on detec-activation in the lamina propria remain to be understood,
tion of anti-transglutaminase antibodies, presence of HLA DQ2 orit is significant that exposure to gluten in vitro was re-
DQ8, villous atrophy, and clinical and histological response to glu-ported to induce innate immune reactions including IL15
ten-free diet. At the time of study, 35 had active celiac disease with
(Maiuri et al., 2003), perhaps initiating the deleterious partial villous atrophy whereas 25 had been under strict gluten-free
series of events leading to uncontrolled destruction of IEC. diet (GFD) for 1–3 years. The GFD patients had become negative
for anti-transglutaminase antibodies and recovered a normal or sub-The recent reports that NKG2D and IL15 reduced the
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normal villous architecture. Twenty-five individuals undergoing ei- TALL-104
ther gastric bypass for morbid obesity or endoscopies and biopsies The TALL-104 line is a CD8 TCR cytotoxic cell line established
for functional intestinal disorders of nonceliac origin, as described from the blood of a child in relapse of acute lymphoblastic leukemia
previously (Jabri et al., 2000; Taunk et al., 1992), were studied as (ATCC). It is cultured in Iscove’s modified Dulbecco’s medium with
controls. Lymphocytes and epithelial cells were isolated from biop- 100 U/ml recombinant human IL2 and 20% FCS.
sies or surgical specimens. All subjects gave written informed con-
sent and research was approved by institutional review boards. Cell Staining and Flow Cytometric Analysis
For surface staining, cells were incubated with fluorochrome or
Antibodies biotin-conjugated antibodies according to standard protocols. Bio-
Biotin or fluorochrome conjugated anti-CD3, -CD8, -TCR, tinylated antibodies and unconjugated antibodies were revealed
-TCR, -CD103, -CD16, -CD56, -CD45RO, unconjugated anti-CD3 with PE-conjugated streptavadin (PharMingen) and appropriate
(clone UCTH1, IgG1), and mouse isotype-matched control Ig were conjugated F(ab’)2 goat anti-mouse IgG isotype, respectively. Fluo-
purchased from PharMingen (San Diego, CA); anti-CD8 mAb was rescence was analyzed on a 4-color FACSCalibur (Becton Dickin-
from Coulter-Immunotech (Miami, FL); anti-epithelial-specific anti- son), with quadrants set to score as negative 	99% of control Ig-
gen (ESA) conjugated to FITC was from Biomeda (Foster City, CA); stained cells.
anti-NKG2D mAb 1D11 (IgG1) was used unconjugated or biotinyl-
ated (Bauer et al., 1999); anti-MIC mAb 6D4 and N2DL-1, -2/
Functional Assays
ULBP-1, -2 were unconjugated (Groh et al., 1996; Steinle et al.,
Cytotoxicity Assay
2001); PE-conjugated goat anti-mouse IgG1 and IgG2a sera were 51Chromium-release assay was performed as previously described
obtained from Southern Biotechnology (Birmingham, AL); and bio-
using P815 cells (a FcR mouse mastocytoma, ATCC), C1R-MICAtinylated antibodies were revealed with PE-conjugated streptavadin
*001 and *004 or control C1R transfectants, various epithelial cell(PharMingen). Anti-DAP12 (DX37) (Lanier et al., 1998) and rabbit
lines, and the NK target cell line K562 at the indicated effector:targetanti-DAP10 (Diefenbach et al., 2002; Wu et al., 2000) were generated
(E:T) ratio in duplicate (fresh cells) or triplicate (cell lines and clones)as previously described; anti-CD3- mAb, anti-phospho-ERK, and
wells. For Fc-dependent redirected cytotoxicity, effectors and tar-anti-ERK were purchased from Santa Cruz Biotechnology (Santa
gets were incubated in the presence of soluble anti-NKG2D and/orCruz, CA); anti-Vav, anti-ZAP70, and anti-phospho-ZAP70 were from
anti-CD3. Control mouse mAbs were MOPC-21 (IgG1) or an IgG1Cell Signaling Technology (Beverly, MA); anti-phospho-JNK and
mAb against human HLA class I (PharMingen). Chromium releaseanti-JNK2 polyclonal antibodies were purchased from Promega
was measured using a scintillation counter (Packard, Meriden, CT).(Madison, WI) and Santa Cruz, respectively; anti-c-Jun-N antibody
The percentage of specific cytotoxicity was calculated using thewas from Cell Signaling Technology; anti-phosphotyrosine mAb
formula 100  (cpm experimental  cpm spontaneous)/(cpm4G10 was from Upstate Biotechnology (Lake Placid, NY); and goat
maximum cpm spontaneous). When indicated, effector cells wereanti-mouse F(ab’)2 was from Jackson Immunoresearch Laboratories
treated for 30 min prior to the cytotoxic assay with the 500 nM(West Grove, PA).
Wortmannin, 50 M Ly294002, 50 M PD98059, 5 M SB203580,
25 mM SP600125, or equivalent concentrations of the DMSO diluent.Recombinant Cytokines
Blocking experiments with anti-NKG2D (1D11 mAb) and anti-MICIL15, IL12, IL7, and IL2 were from PharMingen.
(6D4) were performed as described previously (Bauer et al., 1999).
Cytolytic Granule Release AssayKinase Inhibitors and SAPK/JNK Assay Kit
Cytolytic granule release was measured as previously describedThe PI3 kinase inhibitor wortmannin and LY294002 were purchased
(Billadeau et al., 2003; Groh et al., 2001; Jamieson et al., 2002).from Sigma (St. Louis, MO) and Calbiochem (La Jolla, CA), respec-
Maximum granule release was determined using 0.2% Triton X100.tively; MEK1/2 inhibitor PD98059, JNK2 inhibitor SP600125, and p38
Esterase release was measured against a standard N-benzyloxycar-inhibitor SB203580 were from Calbiochem; the SAPK/JNK assay kit
bony lysine thiobenzyl ester (BLT) esterase.was from Cell Signaling Technology.
Cell Isolation, Cell Line Generation, and Cell Culture Cell Signaling Biochemistry
Intraepithelial CTL and Intestinal Epithelial Cell Isolation To look at ERK and JNK phosphorylation, cells were serum starved
Intraepithelial CTL and intestinal epithelial cell (IEC) were purified for 30 hr. To test the effects of kinase inhibitors, cells were incubated
from jejunal biopsies as described previously but without using for 30 min at 37C with the indicated inhibitors prior to stimulation. To
dithiothreitol (DTT) in order to better preserve the viability of IEC test cytokines, cells were incubated with cytokines for the indicated
(Jabri et al., 2000). Normal intraepithelial CTL were isolated from duration and washed prior to being lysed. To crosslink immunore-
healthy individuals undergoing gastric bypass for morbid obesity ceptors, cells were incubated for 1 min at 37C with isotype-matched
as described previously (Taunk et al., 1992). All freshly isolated control Ig, anti-CD3, or anti-NKG2D before adding goat anti-mouse
intraepithelial CTL studied contained less than 5% CD3 negative IgG F(ab’)2 antibodies for the indicated duration. Cells were lysed for
(which correlated with the absence of killing of NK targets such as 20 min in a lysis buffer containing fresh protease and phosphatase
K562, which do not express NKG2D ligands) and TCR lympho- inhibitors (50 mM Tris-Hcl [pH 7.5]; 150 mM NaCl; 1% Triton-X100;
cytes. 1 mM EDTA; 1 mM Na3VO4; 1 mM NaF; and protease inhibitor cocktailNKG2D Intraepithelial CTL Lines and Clones tablets). For detection of ERK1/2, JNK, phospho-ZAP70, and total
NKG2DTCRCD8 intraepithelial CTL lines and clones were ob- ZAP70, total lysates were subjected to SDS-PAGE electrophoresis.
tained and cultured as previously described (Jabri et al., 2002).
JNK kinase assays were done according to kit instructions (Cell
CD45RO and CD45RO TCRCD8 PBL
Signaling Technologies) using c-Jun-N-GST fusion protein coupled
Peripheral blood lymphocytes (PBL) were isolated from whole blood
to glutathione beads. Phosphorylated ERK1/2, JNK, c-Jun, andof healthy volunteers after Ficoll density gradient centrifugation
ZAP70 were revealed with anti-phospho-ERK1/2 (Thr202/Tyr304)(Amersham Pharmacia Biotech, Piscataway, NJ). Cells were stained
and phospho-JNK and anti-phospho-c-Jun-N (Ser63) and anti-with anti-CD8, -CD45RO, -TCR to FACS-sort TCRCD8C-
phospho-ZAP70 (Tyr319), respectively, followed by HRP-conju-D45RO and RO PBL. Indeed, CD8 staining discriminates against
gated goat anti-mouse or donkey anti-rabbit Abs (Jackson Immu-NK cells, and TCR staining allows exclusion of  T cells.
noresearch Laboratories) using the enhanced chemiluminescenceC1R-MICA and Control Transfectants
ECL kit from Amersham Pharmacia Biotech. To assess variations inC1R cell transfectants expressing MICA (alleles *001 or *004) C1R-
loading gel lanes, membranes were stripped according to standardMIC and control C1R-Neo have been described (Groh et al., 2001).
procedures and stained with antibodies to ERK, JNK, and c-Jun.LOVO, INT-407, and HCT-116
These intestinal cell lines have been described (Groh et al., 2001).
ImmunohistochemistryK562 Erythroleukemia Cell Line
Immunohistochemical staining for MIC A/B was performed as de-This was obtained from the American type culture collection (ATCC,
scribed (Groh et al., 2001) on 4 m cryostat sections from smallManassas, VA) and cultured in RPMI-1640 medium with 10% FCS
and antibiotics. intestinal biopsies. Antibody binding was detected by using second-
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ary anti-mouse antibody conjugated to HRP-labeled polymer (EnVi- Billadeau, D.D., Upshaw, J.L., Schoon, R.A., Dick, C.J., and Leibson,
sion system, DAKO, Carpinteria, CA) and DAB chromogen. Sec- P.J. (2003). NKG2D-DAP10 triggers human NK cell-mediated killing
tions were counterstained with Gill’s 3 hematoxylin. via a Syk-independent regulatory pathway. Nat. Immunol. 4,
Immunohistochemical staining for phospho-ERK1/2 was per- 557–564.
formed on paraffin sections after antigen retrieval (DAKO). Slides Braud, V.M., Allan, D.S., O’Callaghan, C.A., Soderstrom, K., D’An-
were stained with anti-phospho-ERK (10 g/ml, Santa Cruz) fol- drea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H.,
lowed by biotinylated anti-mouse IgG secondary antibody (Vector et al. (1998). HLA-E binds to natural killer cell receptors CD94/
Laboratories), followed by an avidin/horseradish peroxidase conju- NKG2A, B and C. Nature 391, 795–799.
gate (ABC reagent, Vector Laboratories). Signals were visualized
Brooks, C.G. (1983). Reversible induction of natural killer cell activityusing diaminobenzidine (DAB) as the substrate (DAKO), and sections
in cloned murine cytotoxic T lymphocytes. Nature 305, 155–158.were then counterstained with hematoxylin. Double staining was
performed using the double staining blocking kit (DAKO). Rabbit Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R.,
anti-CD3 antibody was used at 1:200 dilution (Oncogen, Seattle, Fanslow, W., Kubin, M., and Chalupny, N.J. (2001). ULBPs, novel
WA). Negative controls included anti-phospho-ERK antibody (10 MHC class I-related molecules, bind to CMV glycoprotein UL16 and
g/ml) preincubated with a blocking peptide (100g/ml, Santa Cruz) stimulate NK cytotoxicity through the NKG2D receptor. Immunity
for 2 hr at RT or mouse IgG2a isotype control (DAKO). 14, 123–133.
Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A.M., Hsia,
Semiquantitative PCR and Real-Time PCR J.K., Vivier, E., and Raulet, D.H. (2002). Selective associations with
Semiquantitative PCR analysis was performed using primers spe- signaling proteins determine stimulatory versus costimulatory activ-
cific for -actin (5-GGGTCAGAAGGATTCCTATG-3; 5-GGTCTCA
ity of NKG2D. Nat. Immunol. 3, 1142–1149.
AACATGATCTGGG-3), DAP10 (5-ATCATCACTCCCTGCCTTTTA
Dubois, S., Mariner, J., Waldmann, T.A., and Tagaya, Y. (2002). IL15-CCC-3; 5-CAGGAACACCGCCCCCACGATGG-3), and NKG2D (5-
Ralpha recycles and presents IL15 in trans to neighboring cells.ACACGATGGCAAAAGCAAAGAT-3; 5-TAGGACATGGGCCACAGT
Immunity 17, 537–547.AAC3).
Quantitative real-time PCR was performed using the iCycler iQ Fehniger, T.A., and Caligiuri, M.A. (2001). Interleukin 15: biology and
real-time PCR detection system (Bio-Rad, Hercules, CA) and SYBR relevance to human disease. Blood 97, 14–32.
green amplification kit (PE Biosystems, Warrington, UK) with the
Fehniger, T.A., Suzuki, K., Ponnappan, A., VanDeusen, J.B., Cooper,same PCR conditions as for semiquantitative PCR (30 cycles, dena-
M.A., Florea, S.M., Freud, A.G., Robinson, M.L., Durbin, J., and Cali-turation at 94C for 30 s and primer annealing/elongation for 15 s
giuri, M.A. (2001). Fatal leukemia in interleukin 15 transgenic miceat 55C using a GeneAmp PCR sytem 9700 (Applied Biosystems).
follows early expansions in natural killer and memory phenotypeNKG2D and DAP10 expression were normalized to glyceraldehyde-
CD8 T cells. J. Exp. Med. 193, 219–231.3-phosphate dehydrogenase (GAPDH) levels. Specific primers: 5-
CATGTTCCAATATGATTCCACC-3; 5-CCTGGAAGATGGTGATGG-3. Gamero, A.M., Ussery, D., Reintgen, D.S., Puleo, C.A., and Djeu,
Relative levels of GAPDH, DAP10, and NKD2D PCR products were J.Y. (1995). Interleukin 15 induction of lymphokine-activated killer
calculated by comparing the threshold cycle (CT) values. The range cell function against autologous tumor cells in melanoma patient
given for NKG2D or DAP10 expression in IL15-treated relative to lymphocytes by a CD18-dependent, perforin-related mechanism.
nontreated intraepithelial CTL was determined by evaluating the Cancer Res. 55, 4988–4994.
expression of 2-CT where CT 
 CTIL15  CTmed and CT 
 Gilfillan, S., Ho, E.L., Cella, M., Yokoyama, W.M., and Colonna, M.
CT  CTGAPDH. (2002). NKG2D recruits two distinct adapters to trigger NK cell acti-
vation and costimulation. Nat. Immunol. 3, 1150–1155.
Statistical Analysis
Green, P.H., and Jabri, B. (2003). Coeliac disease. Lancet 362,Mean fluorescence intensities of NKG2D were compared between
383–391.normal, active celiac, and GFD patients using analysis of variance
(ANOVA) followed by Tukey’s adjustment for multiple comparisons. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M., and
Since the variability within groups increased with the mean, a loga- Spies, T. (1996). Cell stress-regulated human major histocompatibil-
rithmic transformation was applied, which stabilized the variances. ity complex class I gene expressed in gastrointestinal epithelium.
For comparison of percentage of MIC-positive IEC between the Proc. Natl. Acad. Sci. USA 93, 12445–12450.
different groups, a nonparametric Kruskal-Wallis test, followed by
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M.S., Ridell,Dunn’s test for pairwise contrasts, was performed.
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